文献速递技术与安全MR

MR波谱在癌症管理中的应用更新:仪器、采集与分析进展

An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis.
PubMed 文献 · Radiol Imaging Cancer · 2024-01-01

本文综述MR波谱(MRS)在临床癌症管理中的应用进展,涵盖MRS原理、常规代谢物,以及超高频MRI扫描仪与混合系统等仪器进展、氘成像、超极化碳13 MRI与MRS、化学交换饱和转移、扩散加权MRS、MR指纹和快速采集等采集新方法,以及人工智能辅助分析,最后提出促进MRS常规用于癌症管理的未来建议。

要点

  • MRS以无创、无电离辐射方式对组织进行定位、多重化学与分子 profiling,可提供癌症诊断、预后、治疗监测及患者管理的代谢与分子信息。
  • 综述重点介绍三类进展:超高频场强MRI扫描仪与混合系统等仪器、氘成像与超极化碳13 MRI/MRS等采集新方法、人工智能辅助分析。
  • 文末给出促进MRS常规用于癌症管理的未来建议。

核心结论

  • MRS作为无创、无电离辐射的定位多重化学与分子成像方法,可提供癌症诊断、预后、治疗监测和患者管理所需的代谢与分子信息。
  • 综述最后提出促进MRS常规用于癌症管理的未来建议。

研究设计与样本

  • 综述类文章,检索范围与纳入文献数量原文未报告。

关键影像表现/征象

  • MRS可对组织进行定位、多重、无电离辐射的化学与分子 profiling。
  • 代谢重编程是癌症的标志,MRS可据此提供代谢与分子信息。

诊断标准与关键数值

  • 原文未报告诊断标准与关键数值。

临床应用与阅片要点

  • 原文结论部分给出促进MRS常规用于癌症管理的未来建议,未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MR spectroscopy (MRS) is a noninvasive imaging method enabling chemical and molecular profiling of tissues in a localized, multiplexed, and nonionizing manner. As metabolic reprogramming is a hallmark of cancer, MRS provides valuable metabolic and molecular information for cancer diagnosis, prognosis, treatment monitoring, and patient management. This review provides an update on the use of MRS for clinical cancer management. The first section includes an overview of the principles of MRS, current methods, and conventional metabolites of interest. The remainder of the review is focused on three key areas: advances in instrumentation, specifically ultrahigh-field-strength MRI scanners and hybrid systems; emerging methods for acquisition, including deuterium imaging, hyperpolarized carbon 13 MRI and MRS, chemical exchange saturation transfer, diffusion-weighted MRS, MR fingerprinting, and fast acquisition; and analysis aided by artificial intelligence. The review concludes with future recommendations to facilitate routine use of MRS in cancer management. Keywords: MR Spectroscopy, Spectroscopic Imaging, Molecular Imaging in Oncology, Metabolic Reprogramming, Clinical Cancer Management © RSNA, 2024.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Martinez Luque E, Liu Z, Sung D, et al. An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis. Radiol Imaging Cancer. 2024. PMID: 38578207. doi:10.1148/rycan.230101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。